Research desk · GMED · NYSE
GMED Stock
SEC financials, peer compare, and chart. Scores open the matching desk. Research only — not advice.
GLOBUS MEDICAL, INC. · Surgical & Medical Instruments & Apparatus
GLOBUS MEDICAL, INC. financial statements, chart, and peer compare from SEC filings.
GLOBUS MEDICAL, INC. (GMED) provides medical devices, diagnostics, or healthcare products.
- Market cap
- $11.55B
- P/E
- 27.04
- Op. margin
- 17.63%
- Profit margin
- 14.47%
- FCF margin
- 8.43%
- ROE
- 8.95%
Related Health Care stocks: WST stock financials · PODD stock financials · MMSI stock financials · ICUI stock financials · DXCM stock financials
GMED financial statements
Each Compare name is its own block of years. Filing lines are SEC reports; P/E and price sit on that name’s TTM column only.
GMED stock peer compare
Each bar is that name’s percent vs its last TTM, on one zero line. Zero is unchanged. This ticker is the black bar.
Focus chart
Zero is unchanged vs last TTM. Every name is a percent for the metric you pick.
GMED stock peer headlines
Yahoo Finance RSS for GMED and the names in Compare.
| Ticker | Date | Headline |
|---|---|---|
| Loading headlines… | ||
GMED stock price chart
Overlays follow the Compare table.
GMED stock — research snapshot
Screen strengths and watchouts for GMED stock from the latest Misprise snapshot.
Strengths
- Operating margin 17.6% — solid operating leverage.
- Profit margin 14.5% — durable bottom-line quality.
- Revenue CAGR 5Y 30.1% — durable top-line compound.
- EPS CAGR 5Y 31.4% — earnings compounding.
- Debt/equity 0.15 — leverage looks manageable.
Watchouts
- No major red flags on the core screen — still read the filings on your own.
- Rev CAGR 5Y 30.1%
- Rev CAGR 3Y 42.2%
- EPS CAGR 5Y 31.4%
- EPS CAGR 3Y 28.4%
- FCF CAGR 5Y 34.2%
- FCF CAGR 3Y 78.0%
GMED stock FAQs
Short answers for GMED stock — statements, sector, and how this page is meant to be used.
What is GMED stock?
GLOBUS MEDICAL, INC. (GMED) provides medical devices, diagnostics, or healthcare products. GMED stock sits in Health Care (Surgical & Medical Instruments & Apparatus), listed on NYSE.
Where can I find GLOBUS MEDICAL, INC. financial statements?
GLOBUS MEDICAL, INC. financial statements — income statement, balance sheet, and cash flow — are on this GMED stock page, parsed from SEC 10-K and 10-Q filings. Use Annual or Quarterly, then the statement tabs. Research only.
What happened to GMED stock?
This page is a research snapshot of GLOBUS MEDICAL, INC. (GMED) from the latest SEC filings in the Misprise database as of TTM. It is not a news feed or a delisting notice. Open the financial statements, chart, and peer compare below, then read the filings. Research only — not financial advice.
Does this page show the GMED stock price?
The live chart on this GMED stock page is the same TradingView chart as the screener. Statement tables use SEC filings. Any price or multiple on the TTM column is a market snapshot from the last seed, not a real-time quote. Research only.
What sector is GMED stock in?
GLOBUS MEDICAL, INC. is classified in Surgical & Medical Instruments & Apparatus, inside the Health Care sector, and trades on NYSE. This page is a research snapshot, not a full company profile.
How do I read GMED financial statements?
Start with this ticker’s block (TTM, then its fiscal years or quarters). Each Compare name is a separate block of its own periods — not mixed by year. A blank is a period we do not have, not a zero. Research only — not a buy or sell.
Where does the GMED statement data come from?
Income, balance sheet, and cash-flow lines are parsed from SEC company filings (10-K / 10-Q and 20-F). TTM is the last four reported quarters added together, not a separate filing. P/E, forward P/E, price, and market cap are a market quote at last seed — trailing P/E from the quote when available, otherwise last price divided by TTM EPS. They are not 10-K line items and appear on the TTM column only. Research only — not financial advice.
Where can I find the GMED income statement, balance sheet, and cash flow?
On this GMED stock page, open Financial statements and use the Income, Balance sheet, and Cash flow tabs. Growth and valuation sit under More. Filing figures are from SEC reports; valuation multiples are the market snapshot described above.
What is the Misprise Score for GMED stock?
GMED stock currently scores 88/100 (Exceptional (85–100)). GLOBUS MEDICAL, INC. clears the high end of the Misprise screen — multi-year growth, profitability, and balance-sheet quality line up together. The score is a screen of quality, growth, and balance-sheet inputs — not a price target. Compare it in the Misprise screener; it is not a separate score page.
How is the GMED comparison winner decided?
Lead and Tie follow the number printed on each factor row, not a blended category score. Growth, quality, score, current ratio, and coverage: the higher figure leads. Value multiples (P/E, PEG, P/B, P/S) and debt ratios: the lower figure leads. Tie appears only when those printed numbers match. The header winner is whoever takes more of those five rows. CAGR uses the 5-year horizon and drops to 3-year only when both names report it. Research only — not a buy or sell.
What is the Anomaly Score on this GMED page?
Anomaly Score is how unusual a filing pattern is versus this company’s own history and its industry — not the same as Misprise Score. A high anomaly with a weak Misprise Score is often a noisy name. Open the anomaly detector to see the flag. Research only — not financial advice.
What does the green grant dot mean on GMED stock?
A green circle next to the title means this ticker appears in the Misprise grants calendar with a recent federal award (USASpending / SAM). Tap the dot for date, agency, and amount when available. It is a research flag only — not a buy or sell signal.
Is GMED stock a buy?
No recommendation either way. This GMED stock page organizes statements, ratios, and peers so you can do your own work. It is educational only — not advice to buy or sell GLOBUS MEDICAL, INC..